UBS Group’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

UBS Group’s Portfolio IBRN Stock Details IBRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.73K	Buy	199 +132	+197%	+$4.63K	﹤0.01%	8741
2026 Q1	$2.21K	Sell	67 -25	-27%	-$801	﹤0.01%	9334
2025 Q4	$2.97K	Buy	+92	New	+$2.77K	﹤0.01%	9166
2025 Q3	–	Sell	-85	Closed	-$1.86K	–	10575
2025 Q2	$1.86K	Buy	+85	New	+$1.85K	﹤0.01%	9557
2023 Q3	–	Sell	-1	Closed	-$24	–	9681
2023 Q2	$24	Buy	+1	New	+$25	﹤0.01%	8673

Other funds holding IBRN

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

UBS Group's IBRN Position: Q2 2026 in Review

UBS Group increased its iShares Neuroscience and Healthcare ETF (IBRN) stake by 197% in Q2 2026, buying an estimated $4.63K and bringing the position to 199 shares worth $7.73K. The position accounts for ﹤0.01% of the portfolio, ranked #8741.

UBS Group first reported a position in IBRN in Q2 2023 and has held it in 5 quarters since. 5 funds tracked by Wall St. Rank hold IBRN as of Q2 2026.

UBS Group held 199 shares of iShares Neuroscience and Healthcare ETF worth $7.73K as of Q2 2026.
UBS Group bought 132 iShares Neuroscience and Healthcare ETF shares in Q2 2026, an estimated $4.63K.
iShares Neuroscience and Healthcare ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8741 holding.
UBS Group first reported a position in iShares Neuroscience and Healthcare ETF in Q2 2023 and has held it in 5 quarters since.
5 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.